Adjuvant Therapy With Anlotinib for HCC
Clinical trial NCT04947371 · WITHDRAWN
Trial details
- NCT number
- NCT04947371
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-15
- Primary completion
- 2019-03-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.